# Pharmacokinetics of Calcineurin & mTOR Inhibitors in HIV-1 Infected Kidney Transplant Recipients After Switch to BIC/FTC/TAF

> **NCT04993872** · PHASE4 · UNKNOWN · sponsor: **Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba** · enrollment: 5 (actual)

## Conditions studied

- HIV-infected Patient Kidney Transplant Recipient

## Interventions

- **DRUG:** Biktarvy Tab

## Key facts

- **NCT ID:** NCT04993872
- **Lead sponsor:** Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-29
- **Primary completion:** 2023-07-01
- **Final completion:** 2024-07-01
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2023-05-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04993872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04993872, "Pharmacokinetics of Calcineurin & mTOR Inhibitors in HIV-1 Infected Kidney Transplant Recipients After Switch to BIC/FTC/TAF". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04993872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*